Products from TargetMol
TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.
More information at: www.targetmol.com
No results were found for the filter!
NEW
Pardaxin P5 TFA
Item number: TGM-TP2942-10mg
Description: Pardaxin P5TFA is the TFA salt form of Pardaxin P5. This compound is an antimicrobial peptide with a MIC value of 13 µM against Escherichia coli.
| MW: | 3381.87 D |
Please request pricing for this article.
NEW
CBP-1008
Item number: TGM-TP2953-10mg
Description: CBP-1008 is a dual-ligand peptide-drug conjugate (PDC) with MMAE, targeting folate receptor (FRalpha) and TRPV6. It exhibits high binding affinity to FRalpha and low affinity to TRPV6. CBP-1008 shows antitumor activity and can be utilized for research in advanced solid tumors such as colorectal cancer,...
Please request pricing for this article.
NEW
Ac-GpYLPQTV-NH2 acetate
Item number: TGM-TP2964-10mg
Description: Ac-GpYLPQTV-NH2 acetate is a STAT3 inhibitor with an IC50 value of 0.33 µM. It also exhibits antitumor properties. Target: STAT
| MW: | 897.91 D |
Please request pricing for this article.
NEW
RJPXD33
Item number: TGM-TP2965-10mg
Description: RJPXD33 is an inhibitor of LpxD and LpxA, with IC50 values of 3.5 µM and 19 µM, respectively. Additionally, RJPXD33 can inhibit LpxD and LpxA in E. coli, with Kd values of 6 µM and 20 µM. Target: Others
| MW: | 1490.76 D |
Please request pricing for this article.
NEW
VH4127
Item number: TGM-TP2966-10mg
Description: VH4127 is a cyclic peptide designed to target low-density lipoprotein receptors (LDLR) with a KD of 18 nM for hLDLR. Incorporating non-natural amino acid residues, VH4127 binds specifically to epidermal growth factor (EGF) LDLR homologous domains in both rodents and humans. Target: Others
| MW: | 1048.37 D |
Please request pricing for this article.
NEW
VGB3
Item number: TGM-TP2984-10mg
Description: VGB3 is a peptide antagonist of vascular endothelial growth factor receptor 1 (VEGFR1) and VEGFR2, exhibiting anti-angiogenic and anti-tumor properties. It binds to VEGFR1 and VEGFR2, thereby inhibiting VEGF-driven endothelial cell proliferation, migration, and tube formation, as well as suppressing...
| MW: | 1572.76 D |
Please request pricing for this article.
NEW
DOTA-EB-TATE
Item number: TGM-TP2996-10mg
Description: DOTA-EB-TATE is formed by combining the SST peptide derivative DOTA-octreotate with an Evans blue analog (EB). This peptide drug conjugate (PDC) enhances the pharmacokinetics of SSTR2 analogs and reduces PRRT toxicity. Additionally, DOTA-EB-TATE serves in the synthesis/research of radiopharmaceutical...
| MW: | 2329.63 D |
Please request pricing for this article.
NEW
S9-CMC1 TFA
Item number: TGM-TP3001-10mg
Description: S9-CMC1 TFA is a covalent peptide lysine-specific demethylase 1 (LSD1) inhibitor with an IC50 value of 2.53 µM. It selectively targets the active site Cys360 of the enzyme. By inhibiting LSD1 activity, S9-CMC1 TFA elevates H3K4me1 and H3K4me2 levels, inducing G1 cell cycle arrest and apoptosis, thereby...
| MW: | 2158.57 D |
Please request pricing for this article.
NEW
Alkyne-betaAG-TOCA
Item number: TGM-TP3002-10mg
Description: Alkyne-betaAG-TOCA is an octreotide derivative that targets somatostatin receptor subtype 2 (SST2). It is utilized in the synthesis and research of radioconjugates (RDC). Target: Others
| MW: | 1100.22 D |
Please request pricing for this article.
NEW
p21PBP
Item number: TGM-TP3017-10mg
Description: p21PBP, a peptide composed of 20 amino acids, serves as an inhibitor of DNA replication. It specifically binds to the purified proliferating cell nuclear antigen (PCNA) found in extracts from tumor cells. p21PBP holds potential for use in cancer research. Target: DNA/RNA Synthesis
| MW: | 2557.93 D |
Please request pricing for this article.
NEW
SLAFVDVLN
Item number: TGM-TP3019-10mg
Description: SLAFVDVLN is a peptide molecule that functions as a BACE-1 inhibitor, exhibiting a Ki value of 94 nM. Additionally, SLAFVDVLN is capable of reducing the production of Abeta42. Target: Others
| MW: | 977.11 D |
Please request pricing for this article.
NEW
mC46 peptide
Item number: TGM-TP3020-10mg
Description: mC46 (C46) peptide is a membrane-associated fusion peptide inhibitor that effectively impedes the replication and entry of HIV-1. Additionally, mC46 peptide can inhibit CCR5-tropic, CXCR4-tropic, and dual-tropic HIVs, as well as SIV and SHIV. Target: Others
| Keywords: | C46 peptide |
| MW: | 5825.3 D |
Please request pricing for this article.